Treatment of Fibromyalgia With Recovery Factors

Not Applicable

Completed

• Conditions: Fibromyalgia; Chronic Fatigue Syndrome

• Registration Number: NCT04381780
• Lead Sponsor: Practitioners Alliance Network

Brief Summary

Treatment of Fibromyalgia and CFS with Recovery Factors

Detailed Description

Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS

Study Timeline

• Study Start: 2020-05-06
• Study First Submitted: 2020-05-06
• Study First Submitted QC: 2020-05-06
• Study First Posted: 2020-05-11
• Status Verified: 2020-10
• Primary Completion: 2020-12-01
• Study Completion: 2021-01-15
• Last Update Submitted: 2021-10-03
• Last Update Posted: 2021-10-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS

Exclusion Criteria

Under 18 Pregnant Other severe complicating conditions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Composite VAS	6 weeks	Composite of VAS for Fatigue, sleep, cognition, pain and overall well being

Secondary Outcome Measures

Name	Time	Method
FIQ-R	1 month	Fibromyalgia Impact Questionnaire

Trial Locations

Locations (1)

Jacob Teitelbaum MD; 🇺🇸 Kailua, Hawaii, United States